Caribou Biosciences, Inc. SEC filings CRBU
Caribou Biosciences, Inc. has 324 filings in SEC EDGAR's recent list, going back to Sep 23, 2014. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 6, 2026 (exit or restructuring costs, officer or director change, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 10-Q/A | Amended quarterly report | Nov 17, 2023 | Jun 30, 2023 |
| 10-Q/A | Amended quarterly report | Nov 17, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 10-Q | Quarterly report | Nov 8, 2022 | Sep 30, 2022 |
| 10-Q | Quarterly report | Aug 9, 2022 | Jun 30, 2022 |
| 10-Q | Quarterly report | May 9, 2022 | Mar 31, 2022 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Sep 2, 2021 | Jun 30, 2021 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRBU (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Berkeley, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1619856
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.